KB002
KB002 is a humanized monoclonal antibody inhibitor targeting GM-CSF. KB002 has significant immune activity and can be used for asthma, rheumatoid arthritis and chronic Idiopathic thrombocytopenia purpura (ITP) research[1].
Product Specifications
UNSPSC
12352203
Target
Others
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]Molfino N A, et al. A Randomized Placebo-Controlled Safety and Pharmacodynamic Study of KB002, a Chimeric Anti-GM-CSF Monoclonal Antibody, in Patients with Asthma[J]. Journal of Allergy and Clinical Immunology, 2013, 131 (2) : AB229.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1411074-01 0.02 mg (E-Coli)
Recombinant Chlorobium tepidum Tyrosine recombinase XerC (xerC)
Ask
View Details MBS1411074-02 0.02 mg (Yeast)
Recombinant Chlorobium tepidum Tyrosine recombinase XerC (xerC)
Ask
View Details MBS1411074-03 0.1 mg (E-Coli)
Recombinant Chlorobium tepidum Tyrosine recombinase XerC (xerC)
Ask
View Details MBS1411074-04 0.1 mg (Yeast)
Recombinant Chlorobium tepidum Tyrosine recombinase XerC (xerC)
Ask
View Details MBS1411074-05 0.02 mg (Baculovirus)
Recombinant Chlorobium tepidum Tyrosine recombinase XerC (xerC)
Ask
View Details MBS1411074-06 0.02 mg (Mammalian-Cell)
Recombinant Chlorobium tepidum Tyrosine recombinase XerC (xerC)
Ask
View Details